Search Results - "AHLMAN, H."

The gut as the largest endocrine organ in the body by Ahlman, H., Nilsson, O.

“…Secretin, gastrin and cholecystokinin were the first discovered gut hormones. Today we recognize more than 30 gut hormone genes and a multitude of bioactive…”
Get full text

Prognostic factors for survival after surgery for adrenal metastasis by Muth, A, Persson, F, Jansson, S, Johanson, V, Ahlman, H, Wängberg, B

“…Abstract Aim To better define the indications for adrenalectomy for adrenal metastasis we have analysed factors predicting survival in our institutional…”
Get full text

The long-term survival in adrenocortical carcinoma with active surgical management and use of monitored mitotane by Wängberg, B, Khorram-Manesh, A, Jansson, S, Nilsson, B, Nilsson, O, Jakobsson, C E, Lindstedt, S, Odén, A, Ahlman, H

“…Adrenocortical carcinoma (ACC) is a rare tumour disease with sinister prognosis also after attempts to radical surgery; better prognosis is seen for low-stage…”
Get full text

Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS) by Plöckinger, U, Rindi, G, Arnold, R, Eriksson, B, Krenning, E P, de Herder, W W, Goede, A, Caplin, M, Oberg, K, Reubi, J C, Nilsson, O, Delle Fave, G, Ruszniewski, P, Ahlman, H, Wiedenmann, B

Get more information

Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST) by NILSSON, B, SJÖLUND, K, KINDBLOM, L.-G, MEIS-KINDBLOM, J. M, BUMMING, P, NILSSON, O, ANDERSSON, J, AHLMAN, H

“…Palliative imatinib treatment has dramatically improved survival in patients with malignant gastrointestinal stromal tumours, particularly in patients with…”
Get full text

Specific binding and uptake of 131I-MIBG and 111In-octreotide in metastatic paraganglioma--tools for choice of radionuclide therapy by Spetz, J, Dalmo, J, Nilsson, O, Wängberg, B, Ahlman, H, Forssell-Aronsson, E

“…Tumor-specific uptake of the radiolabeled nor-epinephrine analogue meta-iodobenzylguanidine via norepinephrine transporter or radiolabeled somatostatin…”
Get more information

Prolonged survival after hepatic artery embolization in patients with midgut carcinoid syndrome by Swärd, C., Johanson, V., Nieveen van Dijkum, E., Jansson, S., Nilsson, O., Wängberg, B., Ahlman, H., Kölby, L.

“…Background: Hepatic artery embolization (HAE) is a palliative treatment for patients with liver metastases from neuroendocrine tumours. HAE reduces hormonal…”
Get full text

Long‐term outcome of a large series of patients surgically treated for pheochromocytoma by KHORRAM‐MANESH, A., AHLMAN, H., NILSSON, O., FRIBERG, P., ODÉN, A., STENSTRÖM, G., HANSSON, G., STENQUIST, O., WÄNGBERG, B., TISELL, L.‐E., JANSSON, S.

“… Objective.  To analyse the morbidity, mortality and long‐term outcome in a consecutive series of surgically treated patients with pheochromocytoma (PC), or…”
Get full text

Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients by BÜMMING, P, ANDERSSON, J, NILSSON, B, MEIS-KINDBLOM, J. M, KLINGENSTIERNA, H, ENGSTRÖM, K, STIERNER, U, WÄNGBERG, B, JANSSON, S, AHLMAN, H, KINDBLOM, L.-G

“…Malignant gastrointestinal stromal tumours (GIST) have a poor prognosis. Since these tumours are resistant to conventional radiation and chemotherapy, surgery…”
Get full text

Population-based study of the diagnosis and treatment of gastrointestinal stromal tumours by Bümming, P., Ahlman, H., Andersson, J., Meis-Kindblom, J. M., Kindblom, L.-G., Nilsson, B.

“…Background: The aim of this retrospective population‐based study, which was conducted before the introduction of imatinib, was to evaluate the role of surgery…”
Get full text

Uptake of meta-iodobenzylguanidine in neuroendocrine tumours is mediated by vesicular monoamine transporters by KÖLBY, L, BERNHARDT, P, LEVIN-JAKOBSEN, A.-M, JOHANSON, V, WÄNGBERG, B, AHLMAN, H, FORSSELL-ARONSSON, E, NILSSON, O

“…The radio-iodinated noradrenaline analogue meta-iodobenzylguanidine (MIBG) can be used for scintigraphy and radiation therapy of neuroendocrine (NE). The aim…”
Get full text

Successful receptor-mediated radiation therapy of xenografted human midgut carcinoid tumour by KÖLBY, L, BERNHARDT, P, JOHANSON, V, SCHMITT, A, AHLMAN, H, FORSSELL-ARONSSON, E, MÄCKE, H, NILSSON, O

“…Somatostatin receptor (sstr)-mediated radiation therapy is a new therapeutic modality for neuroendocrine (NE) tumours. High expression of sstr in NE tumours…”
Get full text

Prediction of prognosis by echocardiography in patients with midgut carcinoid syndrome by Westberg, G., Wängberg, B., Ahlman, H., Bergh, C. H., Beckman-Suurküla, M., Caidahl, K.

“…Background: The association between malignant midgut carcinoid tumours and right‐sided cardiac lesions is well known, but the pathogenetic link between tumour…”
Get full text

Adjuvant and down-staging treatment with imatinib in gastrointestinal stromal tumors by Nilsson, B., Andersson, A., Ahlman, H.

Get full text

Mortality associated with pheochromocytoma in a large Swedish cohort by Khorram-Manesh, A., Ahlman, H., Nilsson, O., Odén, A., Jansson, S.

“…Background. The aim of the present study was to report the risk of death in a national cohort of patients with aPC (adrenal PC) and their risk of developing a…”
Get full text

The Ki67 index a prognostic marker in medullary thyroid carcinoma by TISELL, L. E, ODEN, A, MUTH, A, ALTIPARMAK, G, MOLNE, J, AHLMAN, H, NILSSON, O

Get full text

Interventional treatment of the carcinoid syndrome by Ahlman, H, Nilsson, O, Olausson, M

“…Liver metastases imply a major problem in patients with carcinoid tumours and hormone overproduction. Patients with distant metastases can undergo resection…”
Get more information

Reducing uncertainty in health-care resource allocation by SIMONSSON, T, SJÖLUND, K, BÜMMING, P, AHLMAN, H, NILSSON, B, ODEN, A

“…A key task for health policymakers is to optimise the outcome of health care interventions. The pricing of a new generation of cancer drugs, in combination…”
Get full text

NESP55, a novel chromogranin-like peptide, is expressed in endocrine tumours of the pancreas and adrenal medulla but not in ileal carcinoids by JAKOBSEN, A-M, AHLMAN, H, KÖLBY, L, ABRAHAMSSON, J, FISCHER-COLBRIE, R, NILSSON, O

“…Neuroendocrine secretory protein 55, NESP55, is an acidic protein belonging to the chromogranin family. The distribution of NESP55 in human tumours is not…”
Get full text

Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours by NILSSON, O, KÖLBY, L, WÄNGBERG, B, WIGANDER, A, BILLIG, H, WILLIAM-OLSSON, L, FJÄLLING, M, FORSSELL-ARONSSON, E, AHLMAN, H

“…We have compared the expression of somatostatin receptor (sstr) subtypes with the outcome of somatostatin receptor scintigraphy and the effect of somatostatin…”
Get full text